l carnitine therapy in non alcoholic steatohepatitis L-carnitine supplementation non-alcoholic fatty liver disease: A systematic review and meta-analysis New Drugs on the Block—Emerging
Description
Recyclable packaging
In contrast to other lcFAODs, congenital malformations, such as dysmorphic features, renal cysts, intracerebral and intrahepatic calcifications have been reported in several cases that suffered from the lethal neonatal form [107,108,109,110]
10.3389/fnsys.2015.00190 Front
It plays a role in converting body fat into energy
